It has been found that cardiac arrest cases could be mitigated via proper statin prescriptions.
Lots of people take statins as a part of their regular regimen in order to lower cholesterol levels. These drugs are prescribed to decrease chances of CV disease. CV disease is common in the mature age group of people.
Don't Miss: The Best HDR TVs
There are people who benefit from taking statins. Nobody wants to end up dead. Statins can be life savers. However, some new research on the matter provides a different angle on the whole situation.
The findings of this new research are published online in Circulation, the journal of the American Heart Association.
"Our study is changing the way we think about prescribing statins; we should not only be considering who is at risk of heart disease but, more importantly, who would benefit from these medications based on randomized clinical trial data," says study-lead author, Dr. George Thanassoulis, who is the director of Preventive and Genomic Cardiology at the MUHC and an associate professor in Medicine at McGill University.
"For example, younger patients who have high cholesterol, are frequently considered too young to be at risk for heart attack in the short term, but our analysis shows that they would benefit from treatment, even in the short term, and therefore should be eligible for statin treatment."
The sort of individuals who ought to be given statins have been pinpointed thanks to the study. The findings were published in a journal online. Preventing heart disease in young people was the goal of the effort.
This study is a game changer. It shows us the mirror by laying it on the line who should be prescribed statins. It is based on a random clinical trial.
Those who are younger and prescribed statins are often thought to be immune to any symptoms of heart attack. However, the latest data shows that even they will benefit from taking statins in the long run.
Over 2134 participants were included in the study. They were selected between the years 2005 and 2010. They represented 71.8 million Americans who were potential receivers of statins.
Two methodologies were followed in their treatment. The individualized approach worked best. Eligibility based upon it was the ideal solution to the dilemma.
Over 9.5 million Americans who were at a lower risk were identified and they received statins. While they were younger, they also had higher levels of LDL which is a strong indicator of future heart attacks.
By targeting them, a grand total of 266,000 heart attacks and strokes could be prevented from occurring over a period of a decade.
Cardiovascular health will never be the same again. Now finally the scientists have a method of uprooting the risk of cardiac problems and strokes via a long term strategy.
By prescribing statins to people who show the least amount of risk, the occurrence of heart attacks and strokes could be minimized in the long run.
The problem was that by the time statins were prescribed, it was often too late. However, by early intervention efforts the very traces of CV disease will be wiped out from the internal systems of the patients.
"Using a benefit-based approach, we identified 9.5 million lower-risk Americans not currently eligible for statin treatment, who had the same or greater expected benefit from statins as higher-risk individuals," explains Dr. Thanassoulis.
"These individuals were lower-risk because they were younger but they also had higher levels of low-density lipoprotein cholesterol which we known to be an important cause of heart disease. Targeting statin treatment to this group would be expected to prevent an additional 266,000 heart attacks and strokes over 10 years."
"This strategy will transform cardiovascular prevention for the better," adds study's co-author, Dr. Allan Sniderman, MUHC cardiologist and associate professor in Medicine at McGill University.
Don't Miss: Incredible Pokemon Gifts
"For too many, the present approach starts too late; an earlier start will multiply the lives saved."